EZZ Life Science Holdings (ASX:EZZ) Gross-Profit-to-Asset % : 161.40% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is EZZ Life Science Holdings Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. EZZ Life Science Holdings's annualized Gross Profit for the quarter that ended in Dec. 2023 was A$30.62 Mil. EZZ Life Science Holdings's average Total Assets over the quarter that ended in Dec. 2023 was A$18.97 Mil. Therefore, EZZ Life Science Holdings's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 161.40%.

EZZ Life Science Holdings Gross-Profit-to-Asset % Historical Data

The historical data trend for EZZ Life Science Holdings's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EZZ Life Science Holdings Gross-Profit-to-Asset % Chart

EZZ Life Science Holdings Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

Gross-Profit-to-Asset %

105.28

57.09

178.84

EZZ Life Science Holdings Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial			50.23	69.48	152.56	213.09	161.40

Competitive Comparison of EZZ Life Science Holdings's Gross-Profit-to-Asset %

For the Biotechnology subindustry, EZZ Life Science Holdings's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EZZ Life Science Holdings's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, EZZ Life Science Holdings's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where EZZ Life Science Holdings's Gross-Profit-to-Asset % falls into.

EZZ Life Science Holdings Gross-Profit-to-Asset % Calculation

EZZ Life Science Holdings's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Jun. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Jun. 2023 )	/	( (Total Assets (A: Jun. 2022 )	+	Total Assets (A: Jun. 2023 ))	/ count )
	=	28.53	/	( (14.265	+	17.641)	/ 2 )
	=	28.53	/	15.953
	=	178.84 %

EZZ Life Science Holdings's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	30.616	/	( (17.641	+	20.297)	/ 2 )
	=	30.616	/	18.969
	=	161.40 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

EZZ Life Science Holdings Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of EZZ Life Science Holdings's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

EZZ Life Science Holdings (ASX:EZZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EZZ Life Science Holdings Ltd (ASX:EZZ) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

104 Derby Street, Silverwater, NSW, AUS, 2128

Website

https://www.ezzlife.com.au

EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.

EZZ Life Science Holdings (ASX:EZZ) Headlines

No Headlines